Teva Pharmaceutical Industries Limited · TASE:TEVA
Sabag Mark sold 44,710 Teva Pharmaceutical Industries Limited shares (Form 4)
Traded Nov 12, 2026 · Filed Nov 12, 2026
On Nov 12, 2026, Sabag Mark (See "Remarks") sold 44,710 Teva Pharmaceutical Industries Limited shares at US$44.14 for US$1.97M, leaving 80,760 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 44,710 shares
- Price
- US$44.14
- Value
- US$1.97M
- Holding after
- 80,760 shares
- Trading plan
- No
- Role
- See "Remarks"
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Ordinary Shares | Option exercise | 44,710 | US$34.90 | 125,470 | Direct |
| Nov 12, 2026 | Ordinary Shares | Sale | 44,710 | US$44.14 | 80,760 | Direct |
Source
Download original · View original at SEC
Related
- Teva Pharmaceutical Industries Limited
- Sabag Mark
- Teva Pharmaceutical Industries Limited shareholders
- Form 4 · Sabag Mark · Nov 6, 2026
- Form 4 · Sabag Mark · May 4, 2026
- Form 4 · Bergwerk Dov · Nov 17, 2026
- Form 4 · Daniell Richard · Nov 12, 2026
- Form 4 · Francis Richard D · Nov 12, 2026
- Form 4 · Weiss Amir · Nov 12, 2026
- Schedule 13G/A · Menora Mivtachim Holdings LTD. · Nov 10, 2026